Valens Semiconductor Ltd.
VLNNYSETechnology● Active
$2.25
+$0.14(+6.64%)
Market Cap$236909250
P/E Ratio—
52W High$3.71
52W Low$1.1
Valens Semiconductor Ltd.（VLN）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · VLN · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($31.58M) | ($36.58M) | ($19.66M) | ($27.67M) | ($26.53M) |
| Depreciation & Amort. | $2.98M | $2.55M | $1.63M | $1.38M | $1.10M |
| Stock-Based Comp. | $0.00M | $15.12M | $15.03M | $12.09M | $9.87M |
| Change in Working Capital | ($4.36M) | $16.57M | ($3.62M) | ($9.76M) | ($5.83M) |
| Net Cash from Operations | ($12.72M) | $1.02M | ($6.36M) | ($22.09M) | ($21.61M) |
| Investing Activities | |||||
| Capital Expenditure | ($1.07M) | ($1.87M) | ($1.19M) | ($1.11M) | ($1.44M) |
| Purchases of Investments | ($105.56M) | ($141.54M) | ($206.02M) | ($214.52M) | ($121.95M) |
| Sales of Investments | $135.97M | $170.11M | $208.56M | $203.90M | $39.23M |
| Net Cash from Investing | $28.03M | $17.78M | $1.35M | ($11.73M) | ($84.16M) |
| Financing Activities | |||||
| Common Stock Repurchased | ($23.99M) | ($1.02M) | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Cash from Financing | ($23.09M) | ($0.15M) | $1.50M | $0.82M | $135.43M |
| Free Cash Flow | |||||
| Free Cash Flow | ($13.79M) | ($0.85M) | ($7.54M) | ($23.20M) | ($23.05M) |
| FCF Margin %(computed) | -19.52% | -1.47% | -8.96% | -25.58% | -32.61% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解Valens Semiconductor Ltd.
关于Valens Semiconductor Ltd.（VLN）现金流量表
Valens Semiconductor Ltd. 2025财年经营活动现金流($0.01B)，自由现金流($0.01B)（FCF利润率-19.52%），资本支出($0.00B)。
常见问题
VLN · 4 问Valens Semiconductor Ltd. 2025财年自由现金流($0.01B)，同比down1525.9%。
VLN free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10